Matches in Wikidata for { <http://www.wikidata.org/entity/Q94408129> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q94408129 description "article scientifique publié en 2017" @default.
- Q94408129 description "wetenschappelijk artikel" @default.
- Q94408129 description "наукова стаття" @default.
- Q94408129 name "NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION" @default.
- Q94408129 name "NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION" @default.
- Q94408129 type Item @default.
- Q94408129 label "NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION" @default.
- Q94408129 label "NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION" @default.
- Q94408129 prefLabel "NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION" @default.
- Q94408129 prefLabel "NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION" @default.
- Q94408129 P1433 Q94408129-5B8AD1A6-7E16-475A-A5A0-8491C889EF0C @default.
- Q94408129 P1476 Q94408129-B65329F9-A400-4FFB-A4AC-3FEE2E41CAD2 @default.
- Q94408129 P2093 Q94408129-016D7DD3-0935-4ECB-A8C3-F2E7915CE604 @default.
- Q94408129 P2093 Q94408129-116D57EA-9F95-4EA9-995A-17F5117E0ACA @default.
- Q94408129 P2093 Q94408129-280BD48C-2980-4683-9FF1-8C34D7D49F4D @default.
- Q94408129 P2093 Q94408129-2CE64DF2-62CE-42FB-B763-1389CB37E788 @default.
- Q94408129 P2093 Q94408129-3149334A-2DC4-4753-93CB-3864167662D5 @default.
- Q94408129 P2093 Q94408129-3CC4898D-EC8C-40CE-844B-C0D18CC78886 @default.
- Q94408129 P2093 Q94408129-3E0BF871-564B-4E64-9320-5A143FBD74C6 @default.
- Q94408129 P2093 Q94408129-406C7247-F433-42C5-89F5-5CE278871BB3 @default.
- Q94408129 P2093 Q94408129-4A4DF129-1412-4E09-8A3F-07D529F00145 @default.
- Q94408129 P2093 Q94408129-6674B621-90AE-444A-B63B-2EEDD6ABC0E0 @default.
- Q94408129 P2093 Q94408129-7B5B1640-FC3C-465E-AE2D-2D5EE7D67D2D @default.
- Q94408129 P2093 Q94408129-C03D0A17-8F07-46C2-8034-2EAB89959A52 @default.
- Q94408129 P2093 Q94408129-C5F8621E-4EF6-4C5E-97D9-733F03BF766E @default.
- Q94408129 P2093 Q94408129-E5B4291B-1075-4DCB-91FD-A6EC8293ADE5 @default.
- Q94408129 P2093 Q94408129-EF6B44CB-854B-4489-9230-3AFF2E4BA404 @default.
- Q94408129 P2093 Q94408129-F30D36A2-D11F-4D84-B1D1-7328C0412889 @default.
- Q94408129 P304 Q94408129-40DAE9CB-BE1D-4F2D-B7A8-E255BC04A68E @default.
- Q94408129 P31 Q94408129-65A19839-7304-4293-B4E0-C21F21E36550 @default.
- Q94408129 P356 Q94408129-9F2C7B53-0A9D-4E88-B4B4-74636B0C2E11 @default.
- Q94408129 P433 Q94408129-24E84AEC-9AE2-4D62-81DA-43DCC3BDA8F6 @default.
- Q94408129 P478 Q94408129-5F66028F-28A7-499F-9046-4FB21FFF3F07 @default.
- Q94408129 P50 Q94408129-32740F30-A3DF-49F3-BBF4-878180BF13B0 @default.
- Q94408129 P50 Q94408129-4D99E328-0853-4426-BBD0-DB0955254396 @default.
- Q94408129 P50 Q94408129-AE1BC33D-211F-4566-8623-2AB56A4FD044 @default.
- Q94408129 P577 Q94408129-94262AD0-58C5-4F06-B332-C3A3A4CE51DF @default.
- Q94408129 P921 Q94408129-2AE61A35-4C1F-43FD-85C5-FC5168DE08AC @default.
- Q94408129 P921 Q94408129-3DD86E35-FDA4-4CB1-BFAB-9A1FEE7D63CA @default.
- Q94408129 P921 Q94408129-F7BE93A6-1C92-4523-A59B-623A76364311 @default.
- Q94408129 P932 Q94408129-8527C036-B13E-4D1B-AD98-3F8CCE8B2D26 @default.
- Q94408129 P356 NOX168.580 @default.
- Q94408129 P1433 Q15724471 @default.
- Q94408129 P1476 "NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION" @default.
- Q94408129 P2093 "Ahmed Idbaih" @default.
- Q94408129 P2093 "Emilie Le Rhun" @default.
- Q94408129 P2093 "Francois Dubois" @default.
- Q94408129 P2093 "Julien Domont" @default.
- Q94408129 P2093 "Mario Campone" @default.
- Q94408129 P2093 "Martin J B Taphoorn" @default.
- Q94408129 P2093 "Martin van den Bent" @default.
- Q94408129 P2093 "Michael Platten" @default.
- Q94408129 P2093 "Michael Weller" @default.
- Q94408129 P2093 "Michel Fabbro" @default.
- Q94408129 P2093 "Paul M Clement" @default.
- Q94408129 P2093 "Roger Stupp" @default.
- Q94408129 P2093 "Thierry Gorlia" @default.
- Q94408129 P2093 "Vassilis Golfinopoulos" @default.
- Q94408129 P2093 "Walter Taal" @default.
- Q94408129 P2093 "Wolfgang Wick" @default.
- Q94408129 P304 "vi142-vi142" @default.
- Q94408129 P31 Q13442814 @default.
- Q94408129 P356 "10.1093/NEUONC/NOX168.580" @default.
- Q94408129 P433 "Suppl 6" @default.
- Q94408129 P478 "19" @default.
- Q94408129 P50 Q51349290 @default.
- Q94408129 P50 Q84760012 @default.
- Q94408129 P50 Q93118855 @default.
- Q94408129 P577 "2017-11-06T00:00:00Z" @default.
- Q94408129 P921 Q282142 @default.
- Q94408129 P921 Q413299 @default.
- Q94408129 P921 Q42824827 @default.
- Q94408129 P932 "5692842" @default.